Same as Spirovac L5 with added protection against vibrio.

American Livestock Supply, Inc. has taken great care in assembling this label information. But, due to the possibility of human error or manufacture label changes, American Livestock Supply, Inc. disclaims responsibility for use or misuse of this product. Before use, always read and follow the manufacturer's label on the physical product.



PRODUCT CODE AND NAME: Spirovac VL5; 100679, 100680

DESCRIPTION: Spirovac VL5 contains a specially prepared, inactivated and adjuvanted unique strain of Leptospira borgpetersenii serovar hardjo-bovis together with inactivated and adjuvanted cultures of L. Pomona, L grippotyphosa, L canicola, L icterhaemorrhagiae and Campylobacter fetus.

ADVANTAGES: Spirovac VL5 protects against leptospirosis cause by L borgpetersenii serovar hardjo (Type: hardjo-bovis), an antigen not contained in standard L5 vaccines. Spirovac VL5 prevents harjo-bovis bacteria from infecting the kidneys and reproductive tract, stopping transmission. Spirovac VL5 provides 12 month duration of immunity (DOI) against hardjo-bovis, which means less time and labor required, increasing peace of mind. Spirova VL5 provides strong placental and fetal protection helping prevent long-term maintenance host infections. It also is safe for use in pregnant cows, making it easy to implement whole-herd protection. Spirovac VL5 stimulates a vigorous cell-mediated immune response, increasing ability to protect against hardjo-bovis.

DOSAGE AND ADMINISTRATION: General Directions: Vaccination of healthy cattle, including pregnant cows and heifers, is recommended. Shake well. Aseptically administer 5mLsubcutaneously or intramuscularly high on the side of the neck.Primary Vaccinations: Healthy cattle should receive 2 doses administered 4-6 weeks apart with booster doses given as necessary. When used as an aid in preventing genital or fetal infection, booster doses should be completed at least 2 weeks prior to breeding. Primary vaccination with this product in calves from 4 weeks of age with a second dose 4-6 weeks later will prevent infection, colonization and subsequent shedding of serovar hardjo-bovis, a source of further infection in the herd.Revaccination: Annual revaccination with a single dose is recommended. Include all bulls in programs of vaccination. As part of normal biosecurity procedures, all replacement animals should begin a two-dose, course of vaccination upon arrival.

PRECAUTIONS: 1.\tStore away from light a 2-7C. Prolonged exposure to higher temperatures may adversely affect potency. Do not freeze.2.\tUse entire contents when first opened.3.\tSterilized syringes and needles should be used to administer this vaccine.4.\tDo not vaccinate within 21 days before slaughter.5.\tOccasional hypersensitivity reactions may occur up to 18 hours postvaccination. Owner should be advised to observe animals during this period. While this event appears to be rare overall, dairy cattle may be affected more frequently than other cattle. Animals affected may display excessive salivation, incoordination, and/or dyspnea. Animals displaying such signs should be treated immediately with epinephrine or equivalent. In nonresponsive animals, other modes of treatment should be considered.6.\tAs with many vaccines, anaphylaxis may occur after use. Initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy.7.\tThis product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions.

QUESTIONS OR COMMENTS: Technical inquiries should be directed to Pfizer Animal Health Product Support, 1-800-366-5288.